Welcome to Hologic Investor Relations

 Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent and Upcoming Events
Recent News
Jul 1, 2015

Hologic, Inc. (NASDAQ: HOLX) announced today that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010, and Wilmington...

Jun 18, 2015

Hologic, Inc. (NASDAQ: HOLX) announced today that it has priced its previously announced private offering of $1.0 billion aggregate principal amount of 5.250% senior notes due 2022 at an issue...

Jun 18, 2015

Hologic, Inc. (NASDAQ: HOLX) announced today that it has launched, subject to market and other conditions, a private offering of $1.0 billion aggregate principal amount of its senior notes due...

Jun 17, 2015

Hologic, Inc. (NASDAQ: HOLX) announced today that David LaVance has resigned as Chairman of the Company's Board of Directors, and notified the Board that he will not stand for re-election at the...

More ›